ES8800941A1 - Un procedimiento para preparar derivados de dihidropirrol (112-b)-isoquinoleina - Google Patents

Un procedimiento para preparar derivados de dihidropirrol (112-b)-isoquinoleina

Info

Publication number
ES8800941A1
ES8800941A1 ES557208A ES557208A ES8800941A1 ES 8800941 A1 ES8800941 A1 ES 8800941A1 ES 557208 A ES557208 A ES 557208A ES 557208 A ES557208 A ES 557208A ES 8800941 A1 ES8800941 A1 ES 8800941A1
Authority
ES
Spain
Prior art keywords
loweralkyl
intermediates
preparation
naphthyridines
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES557208A
Other languages
English (en)
Other versions
ES557208A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Roussel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharmaceuticals Inc filed Critical Hoechst Roussel Pharmaceuticals Inc
Publication of ES557208A0 publication Critical patent/ES557208A0/es
Publication of ES8800941A1 publication Critical patent/ES8800941A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Display Devices Of Pinball Game Machines (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE DIHIDROPIRROL1,2-B-ISOQUINOLEINA, DE FORMULA GENERAL (I), Y SUS SALES DE ADICION DE ACIDO FARMACEUTICAMENTE ACEPTABLES. CONSISTE EN CICLAR UN COMPUESTO DE FORMULA GENERAL (II), EN LA QUE X ES HIDROGENO, HALOGENO, ALQUILO INFERIOR O ALCOXI INFERIOR, EN CONDICIONES FRIEDEL-CRAFTS, PARA OBTENER UN COMPUESTO DE FORMULA GENERAL (III). A CONTINUACION EL COMPUESTO OBTENIDO DE FORMULA GENERAL (III) SE HACE REACCIONAR CON HIDROXILAMINA. DE APLICACION EN MEDICINA COMO AGENTES REFORZADORES DE LA MEMORIA.
ES557208A 1985-03-13 1986-11-17 Un procedimiento para preparar derivados de dihidropirrol (112-b)-isoquinoleina Expired ES8800941A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/711,327 US4652567A (en) 1985-03-13 1985-03-13 Benzo(c)-1,5-naphthyridines useful for treating a patient having drug induced memory impairment in need of memory enhancement

Publications (2)

Publication Number Publication Date
ES557208A0 ES557208A0 (es) 1987-12-01
ES8800941A1 true ES8800941A1 (es) 1987-12-01

Family

ID=24857642

Family Applications (4)

Application Number Title Priority Date Filing Date
ES552874A Expired ES8707528A1 (es) 1985-03-13 1986-03-11 Un procedimiento para preparar benzo (c)-1,5-naftiridinas
ES557208A Expired ES8800941A1 (es) 1985-03-13 1986-11-17 Un procedimiento para preparar derivados de dihidropirrol (112-b)-isoquinoleina
ES557207A Expired ES8801269A1 (es) 1985-03-13 1986-11-17 Un procedimiento para preparar benzo(c)-1,5-naftiridinas
ES557768A Expired ES8801270A1 (es) 1985-03-13 1987-10-15 Un procedimiento para preparar benzo (c)-1,5-naftiridinas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES552874A Expired ES8707528A1 (es) 1985-03-13 1986-03-11 Un procedimiento para preparar benzo (c)-1,5-naftiridinas

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES557207A Expired ES8801269A1 (es) 1985-03-13 1986-11-17 Un procedimiento para preparar benzo(c)-1,5-naftiridinas
ES557768A Expired ES8801270A1 (es) 1985-03-13 1987-10-15 Un procedimiento para preparar benzo (c)-1,5-naftiridinas

Country Status (19)

Country Link
US (1) US4652567A (es)
EP (1) EP0197318B1 (es)
JP (1) JPS61212585A (es)
KR (1) KR860007255A (es)
AT (1) ATE52510T1 (es)
AU (1) AU590748B2 (es)
CA (1) CA1248108A (es)
DE (1) DE3671017D1 (es)
DK (1) DK114386A (es)
ES (4) ES8707528A1 (es)
FI (1) FI861001A7 (es)
GR (1) GR860681B (es)
HU (2) HU201756B (es)
IL (1) IL78117A0 (es)
NO (1) NO163489B (es)
NZ (1) NZ215439A (es)
PH (1) PH22279A (es)
PT (1) PT82187B (es)
ZA (1) ZA861837B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4766217A (en) * 1984-01-13 1988-08-23 Boehringer Ingelheim Kg Preparation of 5,6-dihydro-pyrrolo[2,1-a]isoquinolines
US5202440A (en) * 1987-10-05 1993-04-13 Pfizer Inc. Certain 9-amino-2-(or 4)-oxa 1,2,3,4-tetrahydro- or 1,2,3,4,5,6,7,8-octahydro-acridines
MX13270A (es) * 1987-10-05 1993-06-01 Pfizer Procedimiento para la preparacion de derivados de 4-aminopiridina
US5994367A (en) * 1997-03-07 1999-11-30 The University Of North Carolina At Chapel Hill Method for treating tumors using 2-aryl-naphthyridin-4-ones

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2273533A1 (fr) * 1974-06-04 1976-01-02 Ferlux Sa Nouveaux derives n-substitues d'acides pyrrolidones-2 carboxyliques-5
US4297358A (en) * 1979-01-16 1981-10-27 Ciba-Geigy Corporation Novel 4,7-phenanthroline derivatives and pharmaceutical compositions containing them and their use
BE880455A (fr) * 1979-01-22 1980-06-06 Sandoz Sa Compositions pharmaceutiques a base d'une benzo (c) (1,6) naphtyridine

Also Published As

Publication number Publication date
ES557208A0 (es) 1987-12-01
ES8801269A1 (es) 1988-01-01
PT82187B (en) 1988-01-07
GR860681B (en) 1986-07-14
IL78117A0 (en) 1986-07-31
ES8707528A1 (es) 1987-08-01
US4652567A (en) 1987-03-24
FI861001A7 (fi) 1986-09-14
EP0197318A1 (en) 1986-10-15
DE3671017D1 (de) 1990-06-13
ES557768A0 (es) 1988-01-01
FI861001A0 (fi) 1986-03-11
HU201756B (en) 1990-12-28
DK114386A (da) 1986-09-14
AU590748B2 (en) 1989-11-16
NZ215439A (en) 1990-03-27
ZA861837B (en) 1987-06-24
AU5465886A (en) 1986-09-18
JPS61212585A (ja) 1986-09-20
KR860007255A (ko) 1986-10-10
ATE52510T1 (de) 1990-05-15
ES8801270A1 (es) 1988-01-01
DK114386D0 (da) 1986-03-12
ES557207A0 (es) 1988-01-01
EP0197318B1 (en) 1990-05-09
HU197007B (en) 1989-02-28
HUT40658A (en) 1987-01-28
PH22279A (en) 1988-07-14
NO860933L (no) 1986-09-15
CA1248108A (en) 1989-01-03
ES552874A0 (es) 1987-08-01
PT82187A (en) 1986-04-01
NO163489B (no) 1990-02-26

Similar Documents

Publication Publication Date Title
ES8801213A1 (es) Un procedimiento para preparar derivados de acridina y ciclopenta (b) guinolina.
GR3026318T3 (en) N-substituted-4-pyrimidinamines and -pyrimidindiamines, a process for their preparation and their use as medicaments
EP0218999A3 (en) New quinazoline derivatives, process for their production and pharmaceutical compositions comprising them
AU635575B2 (en) 4- and 6-carbamates related to physostigmine, a process and intermediates for their preparation and their use as medicaments
GR3003299T3 (en) Alpha-alkyl-4-amino-3-quinoline-methanols and 1-(4-aralkylamino-3-quinolinyl) alkanones, a process for their preparation and their use as medicaments
GR3020612T3 (en) 1-(Pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles, intermediates and a process for their preparation, and their use as medicaments
AU8148387A (en) Fused heterocyclic tetrahydroaminoquinolinols and related compounds, a process for their preparation and their use as medicaments
ES8707528A1 (es) Un procedimiento para preparar benzo (c)-1,5-naftiridinas

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960401